Relaxation techniques may help lower high blood pressure—at least in the short term
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jun-2025 15:09 ET (15-Jun-2025 19:09 GMT/UTC)
Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and cancer cachexia.
The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that the weight loss drugs known as Glucagon-like peptide-1 agonists — GLP-1s — lead to new food and drink consumption patterns, which underscore observed changes in food and beverage marketing. While previous consumer behavior studies have shown GLP-1s caused lower preference for high-fat foods and promoted weight loss, there has been limited information on how it influenced food preferences and consumption behavior across different food categories. For the study, they surveyed current, previous and potential consumers of GLP-1s to better understand how taking these medications affects food choices. The study also included people who did not plan to take a GLP-1.
Nearly half of Americans who smoke use menthol cigarettes that are harder to quit, driving up their health risks with every puff. Now, a new University of Michigan study will test the best way to help people who smoke menthol break that habit.